HOW TO DEAL WITH DECISION UNCERTAINTY? THE ITALIAN EXPERIENCE WITH MANAGED ENTRY AGREEMENTS

被引：0
|
作者：
Siviero, P. D. [1 ]
Sammarco, A. [1 ]
Tafuri, G. [1 ]
Pani, L. [1 ]
机构：
[1] Italian Med Agcy, Rome, Italy
来源：
VALUE IN HEALTH | 2012年 / 15卷 / 04期
关键词：
D O I：
10.1016/j.jval.2012.03.175
中图分类号：
F [经济];
学科分类号：
02 ;
摘要：
引用
收藏
页码：A31 / A31
页数：1
相关论文
共 50 条
  • [21] MANAGED ENTRY AGREEMENTS FOR PRESCRIPTION DRUGS IN SWEDEN
    Gregorsson, M.
    Medin, E.
    Lindblom, J.
    VALUE IN HEALTH, 2019, 22 : S800 - S800
  • [22] Managed Entry Agreements for Oncology Drugs: Lessons from the European Experience to Inform the Future
    Pauwels, Kim
    Huys, Isabelle
    Vogler, Sabine
    Casteels, Minne
    Simoens, Steven
    FRONTIERS IN PHARMACOLOGY, 2017, 8
  • [23] How to Deal With Uncertainty?
    Bouchon-Meunier, Bernadette
    IEEE COMPUTATIONAL INTELLIGENCE MAGAZINE, 2021, 16 (02) : 3 - 3
  • [24] How Managed Entry Agreements Influence the Patients' Affordability to Biological Medicines-Bulgarian Example
    Mitkova, Zornitsa
    Manev, Ivan
    Tachkov, Konstantin
    Boyadzhieva, Vladimira
    Stoilov, Nikolay
    Doneva, Miglena
    Petrova, Guenka
    HEALTHCARE, 2023, 11 (17)
  • [25] INNOVATIVE CONTRACTING: USE OF COMPLEX MANAGED ENTRY AGREEMENTS
    Privolnev, Y.
    VALUE IN HEALTH, 2017, 20 (09) : A657 - A657
  • [26] Integrative Review of Managed Entry Agreements: Chances and Limitations
    Carolina Zampirolli Dias
    Brian Godman
    Ludmila Peres Gargano
    Pâmela Santos Azevedo
    Marina Morgado Garcia
    Maurílio Souza Cazarim
    Laís Lessa Neiva Pantuzza
    Nelio Gomes Ribeiro-Junior
    André Luiz Pereira
    Marcus Carvalho Borin
    Isabella de Figueiredo Zuppo
    Roberto Iunes
    Tomas Pippo
    Renata Curi Hauegen
    Carlos Vassalo
    Tracey-Lea Laba
    Steven Simoens
    Sergio Márquez
    Carolina Gomez
    Luka Voncina
    Gisbert W. Selke
    Livio Garattini
    Hye-Young Kwon
    Jolanta Gulbinovic
    Aneta Lipinska
    Maciej Pomorski
    Lindsay McClure
    Jurij Fürst
    Rosana Gambogi
    Carla Hernandez Ortiz
    Vânia Cristina Canuto Santos
    Denizar Vianna Araújo
    Vânia Eloisa Araujo
    Francisco de Assis Acurcio
    Juliana Alvares-Teodoro
    Augusto Afonso Guerra-Junior
    PharmacoEconomics, 2020, 38 : 1165 - 1185
  • [27] Managed Entry Agreements: Tools of Necessity, Works in Progress
    Beninger, Paul
    CLINICAL THERAPEUTICS, 2025, 47 (02) : 115 - 116
  • [28] ADOPTION OF MANAGED ENTRY AGREEMENTS IN ESTABLISHED AND EMERGING MARKETS
    Xue, Y.
    Montilva, J.
    Degun, R.
    VALUE IN HEALTH, 2016, 19 (07) : A835 - A836
  • [29] Integrative Review of Managed Entry Agreements: Chances and Limitations
    Dias, Carolina Zampirolli
    Godman, Brian
    Gargano, Ludmila Peres
    Azevedo, Pamela Santos
    Garcia, Marina Morgado
    Cazarim, Maurilio Souza
    Neiva Pantuzza, Lais Lessa
    Ribeiro-Junior, Nelio Gomes
    Pereira, Andre Luiz
    Borin, Marcus Carvalho
    Zuppo, Isabella de Figueiredo
    Iunes, Roberto
    Pippo, Tomas
    Hauegen, Renata Curi
    Vassalo, Carlos
    Laba, Tracey-Lea
    Simoens, Steven
    Marquez, Sergio
    Gomez, Carolina
    Voncina, Luka
    Selke, Gisbert W.
    Garattini, Livio
    Kwon, Hye-Young
    Gulbinovic, Jolanta
    Lipinska, Aneta
    Pomorski, Maciej
    McClure, Lindsay
    Furst, Jurij
    Gambogi, Rosana
    Ortiz, Carla Hernandez
    Canuto Santos, Vania Cristina
    Araujo, Denizar Vianna
    Araujo, Vania Eloisa
    Acurcio, Francisco de Assis
    Alvares-Teodoro, Juliana
    Guerra-Junior, Augusto Afonso
    PHARMACOECONOMICS, 2020, 38 (11) : 1165 - 1185
  • [30] Financial Outcomes of Managed Entry Agreements for Pharmaceuticals in Italy
    Trotta, Francesco
    Guerrizio, Maria Alessandra
    Di Filippo, Aurora
    Cangini, Agnese
    JAMA HEALTH FORUM, 2023, 4 (12): : E234611
12345